Ascendis Pharma A/S (ASND) Most Active Options

The 25 most actively traded Ascendis Pharma A/S (ASND) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$276.58
52-week range
$67.45 – $344.13
ATM IV (30d)
45.4%
IV rank
46 / 100
Moderate
Expected move
±$17.39 (±6.3%)
Put/call OI
0.30
Call-heavy
Max pain
$240
↓ 13.2% below close

Most Active ASND Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
ASND $290 call Aug 21, 2026 42d $9.00 46.7% 43 0.37 26 45 5.7× avg
ASND $270 call Oct 16, 2026 98d $25.00 45.4% 67 0.57 0 41 63.0× avg
ASND $300 call Jul 17, 2026 7d $0.40 66.1% 25 0.14 360 26 1.1× avg
ASND $340 call Jul 17, 2026 7d $0.10 77.7% 0 0.02 126 20 14.0× avg
ASND $350 call Aug 21, 2026 42d $0.36 51.3% 39 0.09 1,000 20 0.5× avg
ASND $320 call Aug 21, 2026 42d $2.74 40.6% 15 0.13 1,071 11 0.9× avg
ASND $175 put Dec 17, 2027 525d $8.91 41.7% 3 -0.11 2 10 135.2× avg
ASND $260 call Aug 21, 2026 42d $25.60 47.9% 53 0.64 72 5 3.2× avg
ASND $250 put Aug 21, 2026 42d $8.30 47.4% 65 -0.28 45 5 0.7× avg
ASND $270 call Dec 17, 2027 525d $59.40 41.2% 22 0.64 10 5 7.7× avg
ASND $250 call Jul 17, 2026 7d $24.30 47.8% 81 0.89 337 5 3.2× avg
ASND $320 call Jul 17, 2026 7d $0.10 86.2% 68 0.09 67 4 0.2× avg
ASND $155 call Sep 18, 2026 70d $118.50 63.5% 49 0.98 3 3 7.0× avg
ASND $270 call Jul 17, 2026 7d $6.50 45.4% 0 0.53 189 3 3.0× avg
ASND $300 call Dec 18, 2026 161d $19.50 41.1% 51 0.43 430 2 2.4× avg
ASND $370 put Sep 18, 2026 70d $98.00 49.8% 55 -0.90 2 5.4× avg
ASND $260 call Sep 18, 2026 70d $27.20 48.0% 53 0.63 73 2 1.3× avg
ASND $330 call Aug 21, 2026 42d $2.60 42.6% 14 0.10 1,010 1 0.0× avg
ASND $280 call Jul 17, 2026 7d $4.36 45.7% 0 0.31 154 1 0.0× avg
ASND $290 call Jul 17, 2026 7d $2.60 55.1% 100 0.19 436 1 0.0× avg
ASND $200 call Aug 21, 2026 42d $72.50 54.8% 42 0.96 5 1 2.3× avg
ASND $300 call Aug 21, 2026 42d $6.00 44.8% 44 0.28 97 1 0.1× avg
ASND $310 call Aug 21, 2026 42d $6.50 43.3% 34 0.20 5 1 0.1× avg
ASND $230 call Jul 17, 2026 7d $40.65 69.1% 41 0.96 43 1 12.0× avg
ASND $300 call Sep 18, 2026 70d $11.57 44.4% 42 0.34 1 1 0.1× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active ASND contract today is the $290 call expiring in 42 days, with 45 contracts traded. Calls dominate the most-active list (22 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on ASND for free

Build multi-leg ASND strategies, visualize payoffs, and scan the full US options universe with OptiView.

ASND Options FAQ

Which ASND option contract is most active today?

The most traded ASND contract is the $290 call expiring Aug 21, 2026, with 45 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active ASND options?

The table lists the 25 ASND contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.